Pfizer loses appeal in UK patent case over use of Lyrica drug for pain

LONDON (Reuters) - Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a patent case over the use of its $5 billion-a-year drug Lyrica for pain relief.